BIOCAD
Marat Malyshev is an experienced professional in pharmaceutical marketing and product management, currently serving as Nosology Lead in the Global Strategy Team at BIOCAD, focusing on immunology and infection since April 2023. Previously, in the role of Group Product Manager for the oncology portfolio in CIS countries, responsibility included managing innovative and biosimilar oncology brands. Marat's extensive background includes significant positions at AstraZeneca, where as Group Product Manager, launches of multiple brands were executed in Uzbekistan, Belarus, and Mongolia, as well as experience at Egis Pharmaceuticals PLC, Teva Pharmaceuticals, and Solvay Pharmaceuticals. Marat's educational qualifications include an MD in anesthesiology and resuscitation from the Russian Medical Academy of Postgraduate Education and an MD in Pediatrics from Rostov State Medical University.
This person is not in the org chart
This person is not in any teams
BIOCAD
6 followers
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.